These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 19939366

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS, Joo BS, Moon SE, Lee SK, Kim KS, Koo JS.
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [Abstract] [Full Text] [Related]

  • 4. Oocyte quality and IVF outcome after coasting to prevent ovarian hyperstimulation syndrome.
    Delvigne A, Kostyla K, Murillo D, Van Hoeck J, Rozenberg S.
    Int J Fertil Womens Med; 2003 Dec; 48(1):25-31. PubMed ID: 12643517
    [Abstract] [Full Text] [Related]

  • 5. Does coasting, a procedure to avoid ovarian hyperstimulation syndrome, affect assisted reproduction cycle outcome?
    Yilmaz N, Uygur D, Ozgu E, Batioglu S.
    Fertil Steril; 2010 Jun; 94(1):189-93. PubMed ID: 19376515
    [Abstract] [Full Text] [Related]

  • 6. Effect of coasting on cycle outcome during in vitro fertilization/intracytoplasmic sperm injection cycles in hyper-responders.
    Kovács P, Mátyás S, Kaali SG.
    Fertil Steril; 2006 Apr; 85(4):913-7. PubMed ID: 16580374
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Can the fall in serum FSH during coasting in IVF/ICSI predict clinical outcomes?
    Datta AK, Zosmer A, Tozer A, Sabatini L, Davis C, Al-Shawaf T.
    Reprod Biomed Online; 2012 May; 24(5):503-10. PubMed ID: 22417663
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Criteria of a successful coasting protocol for the prevention of severe ovarian hyperstimulation syndrome.
    Mansour R, Aboulghar M, Serour G, Amin Y, Abou-Setta AM.
    Hum Reprod; 2005 Nov; 20(11):3167-72. PubMed ID: 16006465
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ovarian hyperstimulation syndrome: steps to maximize success and minimize effect for assisted reproductive outcome.
    Gera PS, Tatpati LL, Allemand MC, Wentworth MA, Coddington CC.
    Fertil Steril; 2010 Jun; 94(1):173-8. PubMed ID: 19356753
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. An elevated basal FSH reflects a quantitative rather than qualitative decline of the ovarian reserve.
    Abdalla H, Thum MY.
    Hum Reprod; 2004 Apr; 19(4):893-8. PubMed ID: 15016786
    [Abstract] [Full Text] [Related]

  • 15. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Papanikolaou EG, Pozzobon C, Kolibianakis EM, Camus M, Tournaye H, Fatemi HM, Van Steirteghem A, Devroey P.
    Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
    [Abstract] [Full Text] [Related]

  • 16. Effects of coasting on the outcome of intracytoplasmic sperm injection-embryo transfer cycles.
    Aktan E, Bozkurt K, Ozer D, Yucebilgin S, Karadadas N, Bilgin O.
    Aust N Z J Obstet Gynaecol; 2004 Aug; 44(4):298-301. PubMed ID: 15281999
    [Abstract] [Full Text] [Related]

  • 17. Coasting. A viable option for patients at risk of ovarian hyperstimulation syndrome.
    Gafar AH, Abotalib ZM.
    Saudi Med J; 2002 Nov; 23(11):1398-401. PubMed ID: 12506304
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
    Peñarrubia J, Fábregues F, Manau D, Creus M, Casals G, Casamitjana R, Carmona F, Vanrell JA, Balasch J.
    Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015
    [Abstract] [Full Text] [Related]

  • 20. Myo-inositol may improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
    Papaleo E, Unfer V, Baillargeon JP, Fusi F, Occhi F, De Santis L.
    Fertil Steril; 2009 May; 91(5):1750-4. PubMed ID: 18462730
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.